-
Product Insights
NewStarpharma Holdings Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Starpharma Holdings Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s development programs include its DEP drug delivery, which is built around dendrimers and VivaGel portfolio. Its flagship product candidate, VivaGel, is a gel-based formulation for...
-
Product Insights
DEP New York City – Hillview Reservoir Improvements – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our DEP New York City - Hillview Reservoir Improvements - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bcl-2-like protein 1 is a potent inhibitor of cell death. The Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) pipeline drugs market research report provides comprehensive information on the Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Bcl 2 Like Protein 1 (Apoptosis...
-
Product Insights
Colon Cancer Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Colon Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
United States Cardiovascular Devices Market Outlook to 2025 – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices and Others
GlobalData’s “United States Cardiovascular Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Cardiovascular Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Clot Management Devices, Electrophysiology Devices, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The United States Cardiovascular Devices...
-
Thematic Analysis
Nanopharmaceuticals – Thematic Research
The global nanopharmaceuticals market size was US$27 billion in 2018 and is expected to grow at CAGR of more than 7% between 2018 and 2025. Nanomedicine is the application of nanotechnology for the diagnosis, prevention, and treatment of disease. It encompasses different applications including drug delivery systems, therapeutic use, imaging, diagnostics, biomaterials, and active implants. The nanopharmaceuticals market research report will assist in developing business strategies by understanding how nanotechnology is being used in healthcare today and how this technology...